Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
OCHA report : 2017 Humanitarian Response Plan End of Year Report (January – December 2017)
December 2017. Humanitarian needs remain staggering in terms of scale, severity and complexity.
ICRC appoints new director-general
10/31/2019. The Assembly of the International Committee of the Red Cross (ICRC) has appointed Robert Mardini to the post of director-general.
Russia scores victory for ally Syria in UN vote cutting aid
01/11/2020. Russia scored a victory for its close ally Syria, using its veto threat to force the U.N. Security Council to adopt a resolution significantly reducing the delivery of cross-border humanitarian aid to over one million Syrians in the northeast.
